Cyberkinetics Neurotechnology Systems, Inc. is a medical device company focused on developing products to treat neurological diseases, and injuries involving the spinal cord and peripheral nerves. The company has electrical stimulation technologies for nerve growth and neural implants combined with signal processing apparatus that access and interact with the cerebral cortex and motor cortex at the level of individual cells. Its product pipeline includes the Andara Oscillating Field Stimulator (OFS) therapy for acute spinal cord injury, which is designed to partially restore sensation and motor function in acute spinal cord injuries; the BrainGate Neural Interface System, which is intended to allow a disabled person to control a computer using thought. The BrainGate System is in clinical evaluation, and the NeuroPort System Neural Signal Processor for neurosurgical monitoring. In May 2008, the Company announced the closing of the sale of its Salt Lake City Research Products business.